Table 1 Summary of prodrugs and their activity.

From: CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model

CDP-Rbo derivatives (simplified abbreviation)

Effective concentration* (μM)

CDP-Rbo

500

CDP(DiA)-Rbo

N.D.

CDP-Rbo(TetA)

200

CDP(DiA)-Rbo(TetA)

N.D.

CDP-Rbo(TetB)

100

CDP(DiA)-Rbo(TetB)

100–200

CDP(DiB)-Rbo(TetB)

50–100

CDP(DiA)-Rbo(TetMOC)

N.D.

CDP(DiA)-Rbo(TetIB)

200

CDP(DiA)-Rbo(TetA)-PB1

10–20

CDP(DiA)-Rbo(TetA)-PB2

50200

  1. Nomenclature of CDP-Rbo derivatives and their activity are summarized. Details for their structural formula are shown in Supplementary Fig. 4. *Effective concentration: concentration required for glycosylation recovery with levels similar to those in WT cells for CDP-Rbo(TetA) or in ISPD-KO cells treated with 200 μM CDP-Rbo(TetA) for other derivatives. N.D.; Not detected.